The life science analytics software market has seen considerable growth due to a variety of factors.
• The market size of life science analytics software has experienced rapid growth in the past few years. The market is projected to expand from $9.77 billion in 2024 to $11.29 billion in 2025 with a compound annual growth rate (CAGR) of 15.6%.
The growth in the historical period can be credited to the increase in diabetes, the proliferation of cardiovascular diseases, the growing use of analytics solutions, the rise in the aging population, and the growing occurrence of healthcare conditions.
The life science analytics software market is expected to maintain its strong growth trajectory in upcoming years.
• Over the next few years, the life science analytics software market is projected to experience rapid expansion. Expected to reach $19.98 billion by 2029 with a compound annual growth rate (CAGR) of 15.3%, this growth during the forecast period can be credited to various factors such as the growing prevalence of chronic and non-communicable diseases, increased clinical trials, population growth, and a rise in patient numbers.
The forecast period is also expected to see major trends including new drug therapy advancements, medical technology innovations, improvements in artificial intelligence, the advent of cloud-based platforms, and the introduction of patient engagement platforms.
The growth of the life science analytics software market is projected to be driven by the escalating number of clinical trials. Clinical trials, which are research studies carried out on humans to assess the effectiveness and safety of medical interventions such as treatments, drugs, devices, or preventative measures, help to satisfy the growing demand for innovative treatments and to tackle the rising global disease burden. Analyzing and interpreting trial data, optimizing processes, and ensuring regulatory compliance for improved decision-making and patient outcomes are among the uses of Life Science Analytics Software in clinical trials. For example, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported in November 2023 that the total number of industry clinical trials launched per year in the UK witnessed a slight rise of 4.3%, increasing from 394 in 2021 to 411 in 2022. This increased number of clinical trials, therefore, propels the life science analytics software market.
The life science analytics softwaremarket covered in this report is segmented –
1) By Product: Prescriptive Analytics, Descriptive Analytics, Predictive Analytics
2) By Delivery Model: On-Premise, Cloud
3) By Application: Research And Development, Sales And Marketing Support, Regulatory Compliance, Supply Chain Analytics, Pharmacovigilance
4) By End User: Pharmaceutical And Biotechnology Companies, Medical Device Companies, Research Centers, Third Party Administrators
Subsegments:
1) By Prescriptive Analytics: Decision Optimization Software, Simulation and Scenario Modeling Tools, Workflow Automation Solutions
2) By Descriptive Analytics: Data Visualization Tools, Reporting and Dashboard Solutions, Real-Time Monitoring Tools
3) By Predictive Analytics: Predictive Modeling Software, Machine Learning and AI Tools, Risk Assessment and Forecasting Solutions
Major players in the life science analytics software market aim to gain a competitive edge through the advancement of technology such as AI-driven analytics platforms. These sophisticated software systems utilize AI and machine learning algorithms to process significant amounts of data, detect patterns, and offer insights. For example, in February 2024, Trinity Life Sciences, an American life sciences consulting corporation, introduced Brand Insights AI, an innovative chat-based AI interface designed to augment the analysis and implementation of biopharmaceutical brand research. This groundbreaking tool accelerates the data synthesis process for insights and analytics teams, enabling them to rapidly retrieve and process large amounts of historical data from various sources. By identifying underlying patterns and expediting decisions, Brand Insights AI provides a revolutionary tool for life sciences executives seeking to improve research procedures and boost strategic results.
Major companies operating in the life science analytics software market are:
• McKesson Corporation
• Accenture Plc
• International Business Machines Corporation (IBM)
• Oracle Corporation
• Cognizant Technology Solutions Corporation
• Koninklijke Philips N.V.
• IQVIA
• Wipro Limited
• Genpact
• EPIC Systems Corporation
• PerkinElmer Inc.
• SAS Institute Inc.
• Veeva Systems Inc.
• M3 (EU) Ltd.
• ExlService Holdings Inc.
• eClinicalWorks
• TIBCO Software Inc.
• Allscripts Healthcare LLC
• Computer Programs and Systems Inc.
• Elinext
• Analytics8
• MaxisIT Incorporated
• Jag products LLC
North America was the largest region in the life science analytics software market in 2024. The regions covered in the life science analytics software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.